Evidence map›Paper›PMID 26895248›Full record

ArticleVirology2016

Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages.

Joseph A Hollenbaugh, Catherine Montero, Raymond F Schinazi, Joshua Munger, Baek Kim

Abstract read
In one paragraph

Article in Virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Macrophages in immunoregulation and therapeutics.Signal transduction and targeted therapy · 2023
    Review
  2. Review
  3. Article
  4. Metabolomics Analysis of Viral Therapeutics.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Joseph A HollenbaughCenter for Drug Discovery, Department of Pediatrics, Health Sciences Research Building, Emory University, 1760 Haygood Drive, Atlanta, GA 30322, USA.
Catherine MonteroCenter for Drug Discovery, Department of Pediatrics, Health Sciences Research Building, Emory University, 1760 Haygood Drive, Atlanta, GA 30322, USA.
Raymond F SchinaziCenter for Drug Discovery, Department of Pediatrics, Health Sciences Research Building, Emory University, 1760 Haygood Drive, Atlanta, GA 30322, USA.
Joshua MungerDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14627, USA.
Baek KimCenter for Drug Discovery, Department of Pediatrics, Health Sciences Research Building, Emory University, 1760 Haygood Drive, Atlanta, GA 30322, USA; Department of Pharmacy, Kyung-Hee University, Seoul, South Korea; Children's Healthcare of Atlanta, Emory University, Atlanta, GA 30322, USA. Electronic address: baek.kim@emory.edu.
Emory University · USUniversity of Rochester Medical Center · US

Funding

Replication fidelity and lentiviral pathogenesisR01AI049781 · NIAID · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2002 to 2016
$4.9M
Therapeutics Targeting Macrophages/Microglia to Eradicate CNS HIV-1 ReservoirsR01MH100999 · NIMH · EMORY UNIVERSITY · PI SCHINAZI, RAYMOND FELIX, TYOR, WILLIAM R · 2013 to 2017
$3.7M
SAMHD1 controls dNTP pool and HIV sensitivity to NRTIsR01GM104198 · NIGMS · UNIVERSITY OF ROCHESTER · PI KIM, BAEK · 2012 to 2018
$2.3M
Metabolic regulatory mechanisms essential for Human Cytomegalovirus replicationR01AI081773 · NIAID · UNIVERSITY OF ROCHESTER · PI MUNGER, JOSHUA C · 2010 to 2014
$1.7M
Replicational Fidelity and Lentivial PathogenesisR56AI049781 · NIAID · EMORY UNIVERSITY · PI KIM, BAEK · 2017 to 2017
$390k
Metabolic regulatory mechanisms essential for Human Cytomegalovirus replicationR56AI081773 · NIAID · UNIVERSITY OF ROCHESTER · PI MUNGER, JOSHUA C · 2015 to 2015
$384k
NIAID NIH HHS AI049781NIAID NIH HHS AI081773NIAID NIH HHS R01 AI049781NIAID NIH HHS R01 AI081773NIAID NIH HHS R56 AI049781NIAID NIH HHS R56 AI081773NIGMS NIH HHS GM104198NIGMS NIH HHS R01 GM104198NIMH NIH HHS MH100999NIMH NIH HHS R01 MH100999
6 · The paper itself

Abstract

We evaluated cellular metabolism profiles of HIV-1 and HIV-2 infected primary human monocyte-derived macrophages (MDMs). First, HIV-2 GL-AN displays faster production kinetics and greater amounts of virus as compared to HIV-1s: YU-2, 89.6 and JR-CSF. Second, quantitative LC-MS/MS metabolomics analysis demonstrates very similar metabolic profiles in glycolysis and TCA cycle metabolic intermediates between HIV-1 and HIV-2 infected macrophages, with a few notable exceptions. The most striking metabolic change in MDMs infected with HIV-2 relative to HIV-1-infected MDMs was the increased levels of quinolinate, a metabolite in the tryptophan catabolism pathway that has been linked to HIV/AIDS pathogenesis. Third, both HIV-1 and HIV-2 infected MDMs showed elevated levels of ribose-5-phosphate, a key metabolic component in nucleotide biosynthesis. Finally, HIV-2 infected MDMs display increased dNTP concentrations as predicted by Vpx-mediated SAMHD1 degradation. Collectively, these data show differential metabolic changes during HIV-1 and HIV-2 infection of macrophages.

Indexed as

MetabolomeCells, CulturedCitric Acid CycleGlycolysisHIV-1HIV-2HIV InfectionsHumansMacrophagesMonocytesGlycolysisHIV-1HIV-2LC–MS/MSMacrophagesMetabolitesTCA

Identifiers

PMID26895248
PMCPMC4834987
OpenAlexW2282677897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.